Literature DB >> 18836830

Analyzing center specific outcomes in hematopoietic cell transplantation.

Brent R Logan1, Gene O Nelson, John P Klein.   

Abstract

Reporting transplant center-specific survival rates after hematopoietic cell transplantation is required in the United States. We describe a method to report 1-year survival outcomes by center, as well as to quantify center performance relative to the transplant center network average, which can be reliably used with censored data and for small center sizes. Each center's observed 1-year survival outcome is compared to a predicted survival outcome adjusted for patient characteristics using a pseudovalue regression technique. A 95% prediction interval for 1-year survival assuming no center effect is computed for each center by bootstrapping the scaled residuals from the regression model, and the observed 1-year survival is compared to this prediction interval to determine center performance. We illustrate the technique using a recent center specific analysis performed by the Center for International Blood and Marrow Transplant Research, and study the performance of this method using simulation.

Entities:  

Mesh:

Year:  2008        PMID: 18836830      PMCID: PMC2709496          DOI: 10.1007/s10985-008-9100-6

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  12 in total

1.  The use of fixed- and random-effects models for classifying hospitals as mortality outliers: a Monte Carlo assessment.

Authors:  Peter C Austin; David A Alter; Jack V Tu
Journal:  Med Decis Making       Date:  2003 Nov-Dec       Impact factor: 2.583

2.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

3.  SAS and R functions to compute pseudo-values for censored data regression.

Authors:  John P Klein; Mette Gerster; Per Kragh Andersen; Sergey Tarima; Maja Pohar Perme
Journal:  Comput Methods Programs Biomed       Date:  2008-01-15       Impact factor: 5.428

Review 4.  Comparing risk-adjustment methods for provider profiling.

Authors:  E R DeLong; E D Peterson; D M DeLong; L H Muhlbaier; S Hackett; D B Mark
Journal:  Stat Med       Date:  1997-12-15       Impact factor: 2.373

5.  Judging hospitals by severity-adjusted mortality rates: the case of CABG surgery.

Authors:  B Landon; L I Iezzoni; A S Ash; M Shwartz; J Daley; J S Hughes; Y D Mackiernan
Journal:  Inquiry       Date:  1996       Impact factor: 1.730

6.  Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example.

Authors:  I-Chan Huang; Francesca Dominici; Constantine Frangakis; Gregory B Diette; Cheryl L Damberg; Albert W Wu
Journal:  Med Decis Making       Date:  2005 Jan-Feb       Impact factor: 2.583

7.  SRTR center-specific reporting tools: Posttransplant outcomes.

Authors:  D M Dickinson; T H Shearon; J O'Keefe; H-H Wong; C L Berg; J D Rosendale; F L Delmonico; R L Webb; R A Wolfe
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

8.  Comparing hospital mortality in adult patients with pneumonia. A case study of statistical methods in a managed care program.

Authors:  A R Localio; B H Hamory; T J Sharp; S L Weaver; T R TenHave; J R Landis
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

9.  Empirical Bayes methods for estimating hospital-specific mortality rates.

Authors:  N Thomas; N T Longford; J E Rolph
Journal:  Stat Med       Date:  1994-05-15       Impact factor: 2.373

10.  The case for case-mix adjustment in practice profiling. When good apples look bad.

Authors:  S Salem-Schatz; G Moore; M Rucker; S D Pearson
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

View more
  12 in total

1.  A Gaussian Copula Model for Multivariate Survival Data.

Authors:  Megan Othus; Yi Li
Journal:  Stat Biosci       Date:  2010-12

Review 2.  Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation.

Authors:  Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

3.  Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

Authors:  William A Wood; Ruta Brazauskas; Zhen-Huan Hu; Hisham Abdel-Azim; Ibrahim A Ahmed; Mahmoud Aljurf; Sherif Badawy; Amer Beitinjaneh; Biju George; David Buchbinder; Jan Cerny; Laurence Dedeken; Miguel Angel Diaz; Cesar O Freytes; Siddhartha Ganguly; Usama Gergis; David Gomez Almaguer; Ashish Gupta; Gregory Hale; Shahrukh K Hashmi; Yoshihiro Inamoto; Rammurti T Kamble; Kehinde Adekola; Tamila Kindwall-Keller; Jennifer Knight; Lalit Kumar; Yachiyo Kuwatsuka; Jason Law; Hillard M Lazarus; Charles LeMaistre; Richard F Olsson; Michael A Pulsipher; Bipin N Savani; Kirk R Schultz; Ayman A Saad; Matthew Seftel; Sachiko Seo; Thomas C Shea; Amir Steinberg; Keith Sullivan; David Szwajcer; Baldeep Wirk; Jean Yared; Agnes Yong; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Yoshiko Atsuta; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-19       Impact factor: 5.742

4.  Comparing center-specific cumulative incidence functions.

Authors:  Ludi Fan; Douglas E Schaubel
Journal:  Lifetime Data Anal       Date:  2015-03-20       Impact factor: 1.588

5.  ROBUST MIXED EFFECTS MODEL FOR CLUSTERED FAILURE TIME DATA: APPLICATION TO HUNTINGTON'S DISEASE EVENT MEASURES.

Authors:  Tanya P Garcia; Yanyuan Ma; Karen Marder; Yuanjia Wang
Journal:  Ann Appl Stat       Date:  2017-07-20       Impact factor: 2.083

6.  Methods for comparing center-specific survival outcomes using direct standardization.

Authors:  Kevin He; Douglas E Schaubel
Journal:  Stat Med       Date:  2014-01-17       Impact factor: 2.373

7.  Benchmarking survival outcomes: A funnel plot for survival data.

Authors:  Hein Putter; Dirk-Jan Eikema; Liesbeth C de Wreede; Eoin McGrath; Isabel Sánchez-Ortega; Riccardo Saccardi; John A Snowden; Erik W van Zwet
Journal:  Stat Methods Med Res       Date:  2022-03-08       Impact factor: 2.494

8.  Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia.

Authors:  Alois Gratwohl; Rafael Duarte; John A Snowden; Anja van Biezen; Helen Baldomero; Jane Apperley; Jan Cornelissen; Hildegard T Greinix; Eoin Mc Grath; Mohamad Mohty; Nicolaus Kroeger; Arnon Nagler; Dietger Niederwieser; Hein Putter; Ronald Brand
Journal:  EClinicalMedicine       Date:  2019-08-09

9.  Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.

Authors:  Sanghee Hong; Ruta Brazauskas; Kyle M Hebert; Siddhartha Ganguly; Hisham Abdel-Azim; Miguel Angel Diaz; Sara Beattie; Stefan O Ciurea; David Szwajcer; Sherif M Badawy; Alois A Gratwohl; Charles LeMaistre; Mahmoud D S M Aljurf; Richard F Olsson; Neel S Bhatt; Nosha Farhadfar; Jean A Yared; Ayami Yoshimi; Sachiko Seo; Usama Gergis; Amer M Beitinjaneh; Akshay Sharma; Hillard Lazarus; Jason Law; Matthew Ulrickson; Hasan Hashem; Hélène Schoemans; Jan Cerny; David Rizzieri; Bipin N Savani; Rammurti T Kamble; Bronwen E Shaw; Nandita Khera; William A Wood; Shahrukh Hashmi; Theresa Hahn; Stephanie J Lee; J Douglas Rizzo; Navneet S Majhail; Wael Saber
Journal:  Cancer       Date:  2020-10-21       Impact factor: 6.860

10.  Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.

Authors:  Alois Gratwohl; Anna Sureda; Helen Baldomero; Michael Gratwohl; Peter Dreger; Nicolaus Kröger; Per Ljungman; Eoin McGrath; Mohamad Mohty; Arnon Nagler; Alessandro Rambaldi; Carmen Ruiz de Elvira; John A Snowden; Jakob Passweg; Jane Apperley; Dietger Niederwieser; Theo Stijnen; Ronald Brand
Journal:  EBioMedicine       Date:  2015-11-19       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.